AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 109 filers reported holding AXSOME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $726,000 | +44.6% | 10,760 | +74.6% | 0.00% | – |
Q4 2020 | $502,000 | -36.0% | 6,162 | -44.0% | 0.00% | -100.0% |
Q3 2020 | $784,000 | -73.8% | 10,999 | -78.3% | 0.00% | -75.0% |
Q1 2020 | $2,989,000 | -5.4% | 50,794 | +66.3% | 0.00% | +33.3% |
Q4 2019 | $3,158,000 | +400.5% | 30,550 | -2.1% | 0.00% | +200.0% |
Q3 2019 | $631,000 | -63.6% | 31,191 | -53.7% | 0.00% | -50.0% |
Q2 2019 | $1,735,000 | +146.4% | 67,373 | -46.4% | 0.00% | +100.0% |
Q4 2017 | $704,000 | +1.0% | 125,670 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $697,000 | -3.6% | 125,670 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $723,000 | +44.6% | 125,670 | -2.0% | 0.00% | – |
Q1 2017 | $500,000 | -32.7% | 128,200 | +16.5% | 0.00% | -100.0% |
Q4 2016 | $743,000 | -12.3% | 110,090 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $847,000 | -5.8% | 110,090 | -7.7% | 0.00% | 0.0% |
Q2 2016 | $899,000 | -12.3% | 119,240 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $1,025,000 | -4.9% | 119,240 | +1.8% | 0.00% | 0.0% |
Q4 2015 | $1,078,000 | – | 117,165 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |